ÂÜÀòÂÒÂ×

Stephen Godin is a Senior Scientist I at Tango Therapeutics with prior experience as a Scientist at Cygnal Therapeutics and as a Postdoctoral Researcher at the University of Massachusetts Boston and Massachusetts Institute of Technology. Stephen holds a PhD in Molecular Genetics and Developmental Biology from the University of Pittsburgh School of Medicine and a BS in Microbiology, General from the University of Massachusetts Amherst. In their various roles, Stephen has focused on understanding mechanisms of cancer predisposition and targeted cancer treatment, as well as developing methods for isolating exosomes from mammalian brain tissue for characterization of their contents.